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Summary 
Background 
Postoperative pain can cause physiological distress, postoperative complications, and extended lengths of hospitalized stay. 
In children, management of postoperative pain is still recognized as being inadequate. 
Objective 
The aim of this trial was to investigate the effects of intraperitoneal ropivacaine on postoperative pain, and recovery of 
bowel function and emetic events after laparoscopic herniorrhaphy in toddlers. 
Methods 
Seventy-six children aged from 9 months to 3 years were recruited between August 2013 and June 2014 at Tongji Hospital 
and randomly assigned into two groups. One group received intraperitoneal ropivacaine right before surgery and the control 
group received intraperitoneal saline. A standard combined general anesthesia procedure was performed under regular 
monitoring. Postoperative pain was assessed by the FLACC scale. Postoperative analgesic consumption, time to flatus, time 
to first stool, and postoperative emetic events were also recorded. 
Results 
When compared with the control group, children who received intraperitoneal ropivacaine experienced less pain 0–4 h after 
surgery [P < 0.001, difference in median FLACC (95% CI) for 2 h time point is 2.00 (0.87–3.13), for 4 h time point is 1.00 
(0.55–1.45)]. In addition, the number of toddlers who received analgesia 0–24 h after surgery in the ropivacaine group was 
lower than that in the control group [P < 0.001, difference in proportions (95% CI) is 0.575 (0.3865–0.7638)]. Compared 
with the control group, time to flatus in ropivacaine group was also much shorter [21.1 h vs 16.7 h, P = 0.04, difference in 
mean (95% CI) is 4.4 (1.49–7.28)], and the time to first stool after surgery was earlier in the ropivacaine group [30.7 h vs 
25.6 h, P = 0.003, difference in mean (95% CI) is 5.1 (1.78–8.45)]. Furthermore, the incidence of emetic events in the 
ropivacaine group was significantly lower than the control group [32.4% vs 11.1%, P = 0.03, difference in proportions (95% 
CI) is 0.212 (0.0246–0.4002)]. 
Conclusion 
The present results indicate that intraperitoneal ropivacaine reduces early postoperative pain and improves recovery after 
laparoscopic herniorrhaphy in toddlers. Therefore, IPLA is a good stratagem for postoperative pain management after 
laparoscopic surgery in toddlers. 
